| Breakdown | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 104.78B | 106.57B | 107.41B | 109.12B | 106.00B |
| Gross Profit | 29.27B | 30.06B | 29.58B | 26.81B | 31.04B |
| EBITDA | 8.01B | 8.65B | 8.60B | 6.60B | 11.97B |
| Net Income | 3.71B | 4.09B | 4.14B | 2.78B | 6.95B |
Balance Sheet | |||||
| Total Assets | 59.49B | 57.77B | 55.36B | 53.34B | 53.81B |
| Cash, Cash Equivalents and Short-Term Investments | 5.49B | 4.76B | 3.81B | 2.23B | 5.91B |
| Total Debt | 5.59B | 19.88B | 19.65B | 19.07B | 16.47B |
| Total Liabilities | 43.33B | 43.10B | 41.92B | 42.10B | 40.98B |
| Stockholders Equity | 16.16B | 14.67B | 13.43B | 11.23B | 12.83B |
Cash Flow | |||||
| Free Cash Flow | 2.83B | 4.48B | 3.81B | -1.51B | 5.08B |
| Operating Cash Flow | 6.56B | 7.37B | 8.62B | 4.02B | 8.63B |
| Investing Cash Flow | -3.65B | -2.86B | -4.76B | -5.50B | -3.15B |
| Financing Cash Flow | -2.19B | -3.55B | -2.29B | -2.20B | -8.07B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $432.50B | 55.55 | 28.81% | 0.59% | 8.34% | 9.58% | |
73 Outperform | $981.08B | 43.44 | 23.69% | 0.85% | 4.34% | 17.27% | |
68 Neutral | $12.68B | 20.97 | 27.41% | ― | 2.82% | 3.77% | |
63 Neutral | $52.70B | 8.81 | 26.06% | 4.79% | -2.16% | -12.66% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | $21.04B | 11.56 | 34.83% | ― | -39.27% | -182.36% | |
55 Neutral | $26.33B | 20.87 | 18.66% | 1.88% | 4.86% | -4.51% |